All Pharma News
price-trendAsk Us
CRO hVIVO reels in £16.8M clinical trial deal for RSV drug

CRO hVIVO reels in £16.8M clinical trial deal for RSV drug
Joseph Keenan FIERCE BIOTECH
13 Dec 2023
Share Share
hVIVO raises 2023 revenue view on demand for respiratory therapy testings

hVIVO raises 2023 revenue view on demand for respiratory therapy testings
REUTERS
12 Sep 2023
Share Share
CRO hVIVO inks deal to test RSV drug in human challenge trial

CRO hVIVO inks deal to test RSV drug in human challenge trial
Joseph Keenan FIERCE BIOTECH
08 Feb 2023
Share Share
Open Orphan signs £10.4 million contract with global pharma client

Open Orphan signs £10.4 million contract with global pharma client
PHARMAFILE
23 Aug 2022
Share Share
Open Orphan to commence influenza human challenge study

Open Orphan to commence influenza human challenge study
John Pinching PHARMA TIMES
05 Aug 2022
Share Share
Vaxart Announces Agreement with hVIVO to Develop Omicron Challenge Model

Vaxart Announces Agreement with hVIVO to Develop Omicron Challenge Model
GLOBENEWSWIRE
30 Jun 2022
Share Share
Open Orphan lands £7.3mln influenza human challenge study

Open Orphan lands £7.3mln influenza human challenge study
PHARMAFILE
19 May 2022
Share Share
Open Orphan subsidiary wins $13.4m contract with US biotech company

Open Orphan subsidiary wins $13.4m contract with US biotech company
Charlie Taylor IRISHTIMES
09 Dec 2021
Share Share
Open Orphan to conduct first-ever COVID-19 human challenge trial

Open Orphan to conduct first-ever COVID-19 human challenge trial
PHARMAFILE
22 Oct 2021
Share Share